Risks of pharmacological interactions of direct oral anticoagulants: thrombotic and hemorrhagic events leading to hospital admission in Catalonia. (IFACOD)

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/48018
• EU PAS number:
  EUPAS48017
• Study ID:
  48018
• Official title and acronym:
  Risks of pharmacological interactions of direct oral anticoagulants: thrombotic and hemorrhagic events leading to hospital admission in Catalonia. (IFACOD)
• DARWIN EU® study:
  No
• Study countries:
  Spain
• Study description:
  Riscos de les interaccions farmacològiques dels anticoagulants orals directes: esdeveniments trombòtics i hemorràgics que són motiu d'ingrés hospitalari a Catalunya.
• Study status:
  Planned

Research institutions and networks

Institutions

Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina, IDIAPJGol

Spain

AQuAS, Agència de Qualitat i Avaluació Sanitàries de Catalunya

Study timelines

Date when funding contract was signed

Planned: 15/04/2022

Actual: 05/07/2022

Study start date

Planned: 01/09/2022

Data analysis start date

Planned: 01/01/2023

Actual: 30/06/2023

Date of final study report

Planned: 30/06/2025

Sources of funding

Other

More details on funding

PADRIS, IDIAP

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable